FDA Issues New Early Stage Guidelines

"The Food and Drug Administration (FDA) announced steps to advance the earliest phases of clinical research in the development of innovative medical treatments. This should make it easier for universities and small drug companies to test promising therapies in humans without having to pay the enormous amounts of expenditures normally required."

Read more in this Patent Baristas post.

Technorati Tags: biotech, biotechnology, fda, medical

Top Ten Life Sciences Decisions

"The United States' most influential courts have made 2005 a vintage year for decisions affecting the life science and pharmaceutical sectors. As the year draws to a close, the time is ripe to review the most significant decisions and evaluate the current state and trends of the living, ever-changing patent jurisprudence." Read more in this article from McDermott Will & Emery via Mondaq (free registration required).